SlideShare a Scribd company logo
1 of 1
.
J Mereckiene 1,9, S Cotter 1,9, K Johansen2, S Tsolova2, P Penttinen2, F D'Ancona3,9, D Levy-Bruhl 4,9, O Wichman7,9, L Demattè5,9, P Valentiner-Branth6,9, I Stankiewicz7,9, D O’Flanagan 1,9 on behalf of the VENICE project gatekeepers group10
Introduction
The European Council recommendation on seasonal
influenza vaccination adopted in 2009 encourages EU/EEA
Member States (MSs) to improve vaccination coverage
among healthcare workers (HCWs). Similarly, the WHO
SAGE in their recommendation from 2012 states that
HCWs are an important priority group.
In the context of these recommendations we assessed
reported policy, available payment schemes and
measured/estimated uptake of seasonal influenza vaccines
in health care workers in EU/EEA countries.
Methods
A standardized online survey questionnaire was developed
by the Vaccine European New Integrated Collaboration
Effort (VENICE III) network and made available in
December 2015 to all EU/EEA MS gatekeepers (n=31).
Descriptive analysis of data on vaccine policy and payment
schemes provided by each responding EU/EEA MS was
carried out. Vaccination coverage rates (VCR) were
calculated as proportions of the number of vaccinated
individuals (numerator) divided by the total number of
individuals in the population groups targeted for vaccination
(denominator) in each MS. VCR information was collected
either by the administrative method or the survey method.
Results
• Of 30 responding countries, 29 recommended seasonal
influenza vaccine to HCWs ahead of the 2014/2015
influenza season. In Denmark, no national
recommendation was available, but most regions and
municipalities offer vaccination free of charge.
• Vaccination was recommended to all HCWs in 24
EU/EEA MS, while another 4 recommend vaccination to
staff in close patient contact or staff caring for
immunocompromised patients only. In the UK,
vaccination was recommended for all HCWs in Northern
Ireland and Scotland, while England and Wales
recommended vaccination of front line HCWs only or
those HCWs who have direct contact with patients.
Policy recommendations, payment schemes and uptake of seasonal influenza vaccine in health care
workers in EU/EEA Member States assessed for the 2009/2010 to 2014/2015 influenza seasons
• No MS enforces mandatory vaccination of staff. Some
health care settings in MSs required unvaccinated staff
to wear a mask during the influenza season.
• Payment schemes for vaccine/vaccination varied, with
the employer, national or regional health services
covering the cost of in 19 MS while 4 reported that at
least some HCWs paid out of pocket. In the remaining
seven countries a combination of several payment
mechanisms exists (e.g. private insurance, out of pocket,
employer or national insurance scheme).
• Uptake of seasonal influenza vaccination in HCWs was
reported from fourteen EU/EEA MS and ranged between
5-55% in 2014-15. Information was collected by the
administrative method (n= 13) or the survey method
(n=1). Uptake in HCWs was often but not always lower
than uptake in older populations, with a median uptake
of ~25% among HCWs (n=17) compared to ~40% in
older populations (n=26).
Figure 2. Seasonal influenza vaccination coverage rates among HCWs in
EU/EEA MSs 2009-10 to 2014-15 influenza seasons
No recommendation
Recommended for all HCWs
Recommended for some* HCWs
* Health care workers in GPs practice/Outpatient health care settings
Conclusions
• Vaccine policy recommendations for HCWs to be
vaccinated against influenza exist in almost all
EU/EEA MSs
• Payment schemes vary but are available in all
EU/EEA MSs.
• Among those EU/EEA MSs reporting uptake there
is room for significant improvement in uptake of
seasonal influenza vaccination in HCWs
• There is a need for collection of uptake of seasonal
influenza vaccination in HCWs in all EU/EEA MSs
Affiliations: 1Health Protection Surveillance Centre, Dublin, Ireland , 2European Centre for Disease Prevention and Control, Stockholm, Sweden, 3Istituto Superiore di Sanità, Rome, Italy, 4Institut de Viellle Sanitaire, Saint-Maurice, France,5CINECA Consortium of Universities, Bologna, Italy, 6Statens Serum Institut, Copenhagen, Denmark,
7Robert Koch Institute, Berlin, Germany, 8National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland, 9Vaccine European New Integrated Collaboration Effort (VENICE) Project, 10The list of gatekeepers is available in the final report on VENICE website: http://venice.cineca.org
Acknowledgements: We are grateful to all VENICE gatekeepers/contact points in each EU/EEA MS that contributed data presented on this poster,
Figure 1. EU/EEA MSs recommending seasonal influenza vaccine for
health care workers.
*Some is defined as e.g. outpatient/inpatient/long term care facilities workers/ front line HCWs/ those
HCWs who have direct contact with patient.
0
10
20
30
40
50
60
70
80
90
100
Vaccinationcoverage(%)
2009-10 2010-11 2011-12 2012-13 2013-14 2014-15

More Related Content

Viewers also liked

Avian influenza in the Netherlands
Avian influenza in the NetherlandsAvian influenza in the Netherlands
Avian influenza in the NetherlandsCornelia Adlhoch
 
HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015Cornelia Adlhoch
 
basic information about avian influenza viruses
basic information about avian influenza virusesbasic information about avian influenza viruses
basic information about avian influenza virusesGeranne Kiezebrink
 
Les 1 neurowetenschappen
Les 1 neurowetenschappenLes 1 neurowetenschappen
Les 1 neurowetenschappengreetdierckx
 
Speaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement PlanSpeaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement PlanStephanie Hogan
 
The Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image SizesThe Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image SizesCustom Creatives
 
Polling system solution using blockchain & Liferay
Polling system solution using blockchain & LiferayPolling system solution using blockchain & Liferay
Polling system solution using blockchain & LiferayDhanraj Dadhich
 
H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?Kenneth Tran
 
The Demographic Effect BEFORE
The Demographic Effect BEFOREThe Demographic Effect BEFORE
The Demographic Effect BEFOREStephanie Hogan
 
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...Lifecare Centre
 

Viewers also liked (13)

Avian influenza in the Netherlands
Avian influenza in the NetherlandsAvian influenza in the Netherlands
Avian influenza in the Netherlands
 
HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015
 
basic information about avian influenza viruses
basic information about avian influenza virusesbasic information about avian influenza viruses
basic information about avian influenza viruses
 
Les 1 neurowetenschappen
Les 1 neurowetenschappenLes 1 neurowetenschappen
Les 1 neurowetenschappen
 
Speaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement PlanSpeaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement Plan
 
Observado
ObservadoObservado
Observado
 
Presentacion elmer hidalgoo
Presentacion elmer hidalgooPresentacion elmer hidalgoo
Presentacion elmer hidalgoo
 
เสนอ2
เสนอ2เสนอ2
เสนอ2
 
The Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image SizesThe Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image Sizes
 
Polling system solution using blockchain & Liferay
Polling system solution using blockchain & LiferayPolling system solution using blockchain & Liferay
Polling system solution using blockchain & Liferay
 
H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?
 
The Demographic Effect BEFORE
The Demographic Effect BEFOREThe Demographic Effect BEFORE
The Demographic Effect BEFORE
 
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
 

More from European Centre for Disease Prevention and Control

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 

Recently uploaded

Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfniloofarbarzegari76
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...ocean4396
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor rawSherrylee83
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...jiyav969
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...marcuskenyatta275
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxDr. Rabia Inam Gandapore
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyNehaa Dubey
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxDr. Sohan Biswas
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Avani bhatt
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSachin Sharma
 

Recently uploaded (20)

Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
Vip ℂall Girls Shalimar Bagh Phone No 9999965857 High Profile ℂall Girl Delhi...
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapy
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 

Policy recommendations, payment schemes and uptake of seasonal influenza vaccine in health care workers in EU/EEA Member States assessed for the 2009/2010 to 2014/2015 influenza seasons

  • 1. . J Mereckiene 1,9, S Cotter 1,9, K Johansen2, S Tsolova2, P Penttinen2, F D'Ancona3,9, D Levy-Bruhl 4,9, O Wichman7,9, L Demattè5,9, P Valentiner-Branth6,9, I Stankiewicz7,9, D O’Flanagan 1,9 on behalf of the VENICE project gatekeepers group10 Introduction The European Council recommendation on seasonal influenza vaccination adopted in 2009 encourages EU/EEA Member States (MSs) to improve vaccination coverage among healthcare workers (HCWs). Similarly, the WHO SAGE in their recommendation from 2012 states that HCWs are an important priority group. In the context of these recommendations we assessed reported policy, available payment schemes and measured/estimated uptake of seasonal influenza vaccines in health care workers in EU/EEA countries. Methods A standardized online survey questionnaire was developed by the Vaccine European New Integrated Collaboration Effort (VENICE III) network and made available in December 2015 to all EU/EEA MS gatekeepers (n=31). Descriptive analysis of data on vaccine policy and payment schemes provided by each responding EU/EEA MS was carried out. Vaccination coverage rates (VCR) were calculated as proportions of the number of vaccinated individuals (numerator) divided by the total number of individuals in the population groups targeted for vaccination (denominator) in each MS. VCR information was collected either by the administrative method or the survey method. Results • Of 30 responding countries, 29 recommended seasonal influenza vaccine to HCWs ahead of the 2014/2015 influenza season. In Denmark, no national recommendation was available, but most regions and municipalities offer vaccination free of charge. • Vaccination was recommended to all HCWs in 24 EU/EEA MS, while another 4 recommend vaccination to staff in close patient contact or staff caring for immunocompromised patients only. In the UK, vaccination was recommended for all HCWs in Northern Ireland and Scotland, while England and Wales recommended vaccination of front line HCWs only or those HCWs who have direct contact with patients. Policy recommendations, payment schemes and uptake of seasonal influenza vaccine in health care workers in EU/EEA Member States assessed for the 2009/2010 to 2014/2015 influenza seasons • No MS enforces mandatory vaccination of staff. Some health care settings in MSs required unvaccinated staff to wear a mask during the influenza season. • Payment schemes for vaccine/vaccination varied, with the employer, national or regional health services covering the cost of in 19 MS while 4 reported that at least some HCWs paid out of pocket. In the remaining seven countries a combination of several payment mechanisms exists (e.g. private insurance, out of pocket, employer or national insurance scheme). • Uptake of seasonal influenza vaccination in HCWs was reported from fourteen EU/EEA MS and ranged between 5-55% in 2014-15. Information was collected by the administrative method (n= 13) or the survey method (n=1). Uptake in HCWs was often but not always lower than uptake in older populations, with a median uptake of ~25% among HCWs (n=17) compared to ~40% in older populations (n=26). Figure 2. Seasonal influenza vaccination coverage rates among HCWs in EU/EEA MSs 2009-10 to 2014-15 influenza seasons No recommendation Recommended for all HCWs Recommended for some* HCWs * Health care workers in GPs practice/Outpatient health care settings Conclusions • Vaccine policy recommendations for HCWs to be vaccinated against influenza exist in almost all EU/EEA MSs • Payment schemes vary but are available in all EU/EEA MSs. • Among those EU/EEA MSs reporting uptake there is room for significant improvement in uptake of seasonal influenza vaccination in HCWs • There is a need for collection of uptake of seasonal influenza vaccination in HCWs in all EU/EEA MSs Affiliations: 1Health Protection Surveillance Centre, Dublin, Ireland , 2European Centre for Disease Prevention and Control, Stockholm, Sweden, 3Istituto Superiore di Sanità, Rome, Italy, 4Institut de Viellle Sanitaire, Saint-Maurice, France,5CINECA Consortium of Universities, Bologna, Italy, 6Statens Serum Institut, Copenhagen, Denmark, 7Robert Koch Institute, Berlin, Germany, 8National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland, 9Vaccine European New Integrated Collaboration Effort (VENICE) Project, 10The list of gatekeepers is available in the final report on VENICE website: http://venice.cineca.org Acknowledgements: We are grateful to all VENICE gatekeepers/contact points in each EU/EEA MS that contributed data presented on this poster, Figure 1. EU/EEA MSs recommending seasonal influenza vaccine for health care workers. *Some is defined as e.g. outpatient/inpatient/long term care facilities workers/ front line HCWs/ those HCWs who have direct contact with patient. 0 10 20 30 40 50 60 70 80 90 100 Vaccinationcoverage(%) 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15

Editor's Notes

  1. Please export the PowerPoint document as a PDF (File – Save as – PDF) and upload the PDF into the system. Please use the font in the document or a similar one and do not use a font size smaller than 16.